uric acid has been researched along with Cancer of the Thyroid in 6 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although lower dosage is now widely accepted, I131 may still be the source of salivary damage over the long-term and subsequent harmful effects on both the oral cavity and the gastrointestinal tract, into which the saliva is swallowed." | 2.73 | Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma. ( Durleshter, L; Ish-Shalom, S; Nagler, RM; Segal, E, 2008) |
| "Ionizing radiation in differentiated thyroid cancer (DTC) patients treated with radioiodine (131-I) produces reactive oxygen species (ROS), which could induce oxidative stress with disturbance of redox balance." | 1.40 | Oxidative stress in patients with differentiated thyroid cancer: early effects of radioiodine therapy. ( Djukic, SM; Jovanovic, MD; Radivojevic, SD; Simonovic, ST; Teodorovic, LC; Vrndic, OB, 2014) |
| "The frequency of cells with chromosomal aberrations, excluding gaps, per 100 cells, increased significantly from 1." | 1.31 | Cytogenetic alterations and oxidative stress in thyroid cancer patients after iodine-131 therapy. ( Ferreira, TC; Gerber, G; Laires, A; Léonard, A; Limbert, E; Monteiro Gil, O; Oliveira, NG; Rodrigues, AS; Rueff, J, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vrndic, OB | 1 |
| Radivojevic, SD | 1 |
| Jovanovic, MD | 1 |
| Djukic, SM | 1 |
| Teodorovic, LC | 1 |
| Simonovic, ST | 1 |
| BANDROVSCHI, A | 1 |
| DIMITRIU, A | 1 |
| MUDRIC, V | 1 |
| Ish-Shalom, S | 1 |
| Durleshter, L | 1 |
| Segal, E | 1 |
| Nagler, RM | 1 |
| Orvoine, RH | 1 |
| Letellier, G | 1 |
| Lapointe, Y | 1 |
| Puig, JG | 1 |
| Mateos, AF | 1 |
| Gaspar, G | 1 |
| Martinez, EM | 1 |
| Ramos, T | 1 |
| Lesmes, A | 1 |
| Monteiro Gil, O | 1 |
| Oliveira, NG | 1 |
| Rodrigues, AS | 1 |
| Laires, A | 1 |
| Ferreira, TC | 1 |
| Limbert, E | 1 |
| Léonard, A | 1 |
| Gerber, G | 1 |
| Rueff, J | 1 |
1 trial available for uric acid and Cancer of the Thyroid
| Article | Year |
|---|---|
Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma.
Topics: Adult; Amylases; Antioxidants; Calcium; Carcinoma; Combined Modality Therapy; Dose-Response Relation | 2008 |
5 other studies available for uric acid and Cancer of the Thyroid
| Article | Year |
|---|---|
Oxidative stress in patients with differentiated thyroid cancer: early effects of radioiodine therapy.
Topics: Adenocarcinoma, Follicular; Antioxidants; Carcinoma, Papillary; Case-Control Studies; Female; Humans | 2014 |
[STUDY OF KREBS CYCLE ACIDS IN CANCER].
Topics: Acids; Arthritis; Arthritis, Rheumatoid; Breast Neoplasms; Chromatography; Citric Acid Cycle; Female | 1964 |
Systemic tolerance of osmotically induced oncolysis in rats.
Topics: Animals; Aspartate Aminotransferases; Body Weight; Diuresis; Drinking; Eating; Female; Fructose; Glu | 1983 |
Hypouricemia and medullary carcinoma of the thyroid.
Topics: Adult; Calcitonin; Female; Humans; Thyroid Neoplasms; Uric Acid | 1984 |
Cytogenetic alterations and oxidative stress in thyroid cancer patients after iodine-131 therapy.
Topics: Adult; Aged; Chromosome Aberrations; Female; Humans; Iodine Radioisotopes; Lymphocytes; Male; Micron | 2000 |